Pharmaceutical Grade 1377049-84-7 Velpatasvir Bakeng sa Phekolo ea Hepatitis C
Sehlahisoalebitso | Velpatasvir |
Litlhaloso tse tšoanang | GS 5816;Methyl [(2S)-1-[(2S,5S)-2-[9-[2-[(2S,4S))-1-[(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl] -4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2- yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
Nomoro ea CAS. | 1377049-84-7 |
Ponahalo | Phofo e tšoeu ho isa ho e mosehla |
Foromo ea limolek'hule | C49H54N8O8 |
Boima ba Molek'hule | 883.00 |
Tšebeliso | Pharmaceutical Grade kapa Research morero |
Ho paka | Joalo ka kopo ea hau |
Polokelo | Boloka ka lijaneng tse thata, tse sa keneleng khanya sebakeng se phodileng |
Velpatasvir Cas: 1377049-84-7 | ||
Lintho | Standard | Liphetho |
Ponahalo | Phofo e tšoeu ho isa ho e mosehla | Phofo e mosehla e khanyang |
Boitsebiso | HPLCIR | E lumellana |
Lintho Tse Amanang | Tšilafalo efe kapa efe ≤0.5%Kakaretso ea Litšila ≤1.0% | 0.15%0.87% |
Metsi(KF) | NMT 3.0% | 2.1% |
Metsoako e setseng | E kopana le litlhoko tsa hajoale tsa ICH | E lumellana |
Masalla a ho Ignition | NMT 0.2% | E lumellana |
Litšepe tse boima | NMT 20ppm | E lumellana |
Tlhahlobo (e thehiloeng ka anhydrous) | 98.0%~102.0% | 98.9% |
Qetello:e tsamaellana le maemo a ka tlung |
Lintlha tsa Khampani
√ Boiphihlelo bo felletseng ba Management layer ho balateli ba lifeme le litsebi tse nang le boiphihlelo; √ Boleng ke kamehla ho nahanela rona holimo, Strict QC tsamaiso; √ lilemo tse 11 tse nang le boiphihlelo sehlopheng sa thekiso ea thepa kantle ho naha; √ Lab e ikemetseng ya R&D; √ Lithupelo tse peli tsa nako e telele tsa GMP; √ Lisebelisoa tse ruileng tsa lifeme tse ngata tse sa sebetseng bakeng sa morero o hlophisitsoeng; √ Sehlopha se sebetsang se sebetsang hantle se nang le tsela e tsitsitseng.Ngola molaetsa wa hao mona mme o re romele wona